Evaluation of Hearing Threshold in Patients with Beta Thalasemia Major Receiving Regular ChelationTherapy with Desferrioxamine (DFO)
The aim of this study was the evaluation of hearing threshold in patients with beta thalasemia major. For this purpose, 178 patients who were under regular chelation therapy with desferrioxamine (DFO) were selected and underwent ear, nose, throat examinations and audiological evaluations. Patients w...
Main Authors: | K Mozafarinia, Z Farahmand, M Ghazvini |
---|---|
Format: | Article |
Language: | English |
Published: |
Kerman University of Medical Sciences
2005-03-01
|
Series: | Journal of Kerman University of Medical Sciences |
Subjects: | |
Online Access: | https://jkmu.kmu.ac.ir/article_32016_2eaf315a4210f929bda65bfc46d648bc.pdf |
Similar Items
-
Metal Coordination Properties of a Chromophoric Desferrioxamine (DFO) Derivative: Insight on the Coordination Stoichiometry and Thermodynamic Stability of Zr<sup>4+</sup> Complexes
by: Matteo Savastano, et al.
Published: (2021-12-01) -
Desferrioxamine-Related Pseudo-Vitelliform Dystrophy and the Effect of Anti-Vascular Endothelial Growth Factor
by: Michael E. Grinton, et al.
Published: (2021-01-01) -
Assessment of the effect of combination therapy with Deferiprone & Desferrioxamine on cardiac complications in major Thalassemia
by: F. Rashidi ghader, M.D, et al.
Published: (2007-01-01) -
Tales of the Unexpected: The Case of Zirconium(IV) Complexes with Desferrioxamine
by: Matteo Savastano, et al.
Published: (2019-06-01) -
Serum ferritin levels, socio-demographic factors and desferrioxamine therapy in multi-transfused thalassemia major patients at a government tertiary care hospital of Karachi, Pakistan
by: Rehman Anis, et al.
Published: (2011-08-01)